Off label prescribing should be aimed at benefiting the individual patient and

Off label prescribing should be aimed at benefiting

This preview shows page 1 - 3 out of 3 pages.

“Off-label” prescribing should be aimed at benefiting the individual patient, and provider must use their best professional judgement to facilitate the best care for their patients. Strategies Used to Make Off-Label Prescribing Safer for Children To make “off label” prescribing safer in children, clinical trials should be conducted and encouraged to improve drug safety. Prescribers should adhere to the professional code of ethics taking care to report any adverse reactions, medication errors, and “off-label” use. Also,
Image of page 1
pediatric investigation plans (PIPs) should be implemented to achieve appropriate drug licenses for use in children. Off-Label Drugs Requiring Extra Attention and Care for Pediatrics Drugs commonly requiring extra care and attention when administering them to pediatric patients include: oxycodone, dexmedetomidine, hydromorphone, lorazepam, ketamine, methadone, milrinone, and dopamine. References American Academy of Pediatrics. (2014, March). Off-label use of drugs in children. Pediatrics, 133(3) , 563-567. doi:10.1542/peds.2013-4060. Retrieved from Arcangelo, V. P., Peterson, A. M., Wilbur, V., & Reinhold, J. A. (Eds.). (2017).
Image of page 2
Image of page 3

You've reached the end of your free preview.

Want to read all 3 pages?

  • Summer '15
  • Pharmacology, pediatric patient, Label Drug Use

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

Stuck? We have tutors online 24/7 who can help you get unstuck.
A+ icon
Ask Expert Tutors You can ask You can ask You can ask (will expire )
Answers in as fast as 15 minutes